test

Alexandra Toohey

@Baker Bros. Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
FATEFate Therapeutics, Inc.
Recent Activity
0.11%
$10.492M
2.998M shares@ $3.5 avg price
ARVNArvinas, Inc.
Recent Activity
New Position
0.11%
$9.989M
405,576 shares@ $24.64 avg price
SANASana Biotechnology, Inc.
Recent Activity
0.11%
$9.905M
2.381M shares@ $4.17 avg price
DSGNDesign Therapeutics, Inc.
Recent Activity
Increased 2.86%
0.1%
$9.381M
1.744M shares@ $5.39 avg price
IONSIonis Pharmaceuticals, Inc.
Recent Activity
New Position
0.1%
$8.952M
223,470 shares@ $40.06 avg price
OPTOpthea Limited
Recent Activity
0.1%
$8.847M
2.174M shares@ $4.08 avg price
CLDXCelldex Therapeutics, Inc.
Recent Activity
0.09%
$8.417M
247,644 shares@ $34.0 avg price
RLAYRelay Therapeutics, Inc.
Recent Activity
0.09%
$8.214M
1.16M shares@ $7.08 avg price
VERVVerve Therapeutics, Inc.
Recent Activity
0.09%
$8.187M
1.692M shares@ $4.84 avg price
TSHATaysha Gene Therapies, Inc.
Recent Activity
0.09%
$8.05M
4.005M shares@ $2.02 avg price